HopeStage
Study directory

Personality disorders studies

Personality disorders involve lasting patterns of thinking, feeling or behaving that can cause distress and difficulties in relationships.

Back to overview
More filters: keywords, city, remote
550studies shown
Showing 241-252 of 550
Other study type icon
UnknownNCT05930912

Psychiatric Orders in Psychoanalytic Treatment of ASD

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

Current recruitment status is unconfirmed.

In Chongqing
Personality disorders, Depression, ...Observational studyAges 18–70
Countries
China
Sponsor
Yang I. Pachankis, PhD
Drug study icon
CompletedEUCTR 2018-001212-30

A trial to study effects of a single dose Citalopram on emotion processing in female patients with Borderline Personality Disorder and the associated modulation of fMRI BOLD signals

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
Personality disordersHistorical research record
Countries
Germany
Sponsor
Central Institute of Mental Health, represented by commercial and administrative Director
Behavioral study icon
CompletedNCT01193205

20 Weeks DBT Group Skills Training Study

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study has finished and is no longer accepting participants.

In Toronto
Personality disordersBehavioural studyAges 18–60
Countries
Canada
Sponsor
Centre for Addiction and Mental HealthHospital / academic medical center
Drug study icon
CompletedNCT04566601

A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study has finished and is no longer accepting participants.

Multiple locations, including Anaheim
Personality disordersMedication studyAges 18–65
Countries
United States, Australia, France, + 12 others
Sponsor
Boehringer Ingelheim
Drug study icon
CompletedNCT04100096

A study of Brexpiprazole in the Treatment of Borderline Personality Disorder

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study has finished and is no longer accepting participants.

Multiple locations, including Bentonville
Personality disordersMedication studyAges 18–65
Countries
United States, Spain, Ukraine
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.Pharmaceutical company
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.